Species differences in the stereochemistry of the metabolism of isoprene in vitro

References

• BLEASDALE C., SMALL, R. D WATSON, W. P., WILSON, J. and GOLDING, B. T., 1996, Studies on the molecular toxicology of buta-1,3-diene and isoprene epoxides. Toxicology, 113, 290–293.
   Google Scholar
• BOND, J. A., BECHTOLD, W. E., BIRNBAUM, L. S., DAHL, A. R., MEDINSKY, M. A., SUN, J. D. and HENDERSON, R. F., 1991,D ispositionof inhaled isoprene in B6C3F1 m ice. Toxkology and Applied Pharmacology, 107, 494–503.
   PubMedGoogle Scholar
• BOND, J. A., RECIO, L. and ANDJELKOVICH, D., 1995, Epidemiologicaland mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace. Carcinogerzesis, 16, 165–171.
   PubMed Web of Science ®Google Scholar
• BOGAARDS, J. J. P., VENEIUiMP, J. C. and VAN BLADEREN, P. J., 1996, The biotransformation of isoprene and the two monoepoxidesby human cytochromeP450 enzymes, compared to mouse and rat liver microsomes. Chemko -Biological Interactions, 102, 169–182.
   Google Scholar
• CAILLEUX, A., MOREUX, X., DELHUMEAU, A. and ALLAIN, P., 1993, Decrease of isoprene concentrations in blood during general anaesthesia. Biochemical and Medical Metabolism Biology, 49, 321–325.
   PubMedGoogle Scholar
• CONKLE, J. P., CAMP, B. J., and WELSCH, B. E., 1975, Trace composition of human respiratory gas. Archives of Environmental Health, 30, 290–295.
   PubMed Web of Science ®Google Scholar
• CSANA'DY, G. A., GUENGERICH, F. P. and BOND, J. A., 1992, Comparison of biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogerzesis, 13, 1143–1153.
   Google Scholar
• DEL MONTE, M., CITTI, L. and GERVASI, P. G., 1985, Isoprene metabolism by liver microsomalmono-oxygenases. Xenobiotka, 15, 591–597.
   PubMedGoogle Scholar
• GERVASI, P. G., CITTI, L., DEL MONTE, M., LONGO, V. and BENETTI, D., 1985, Mutagenicity and chemicalreactivity of epoxide interm ediatesof isoprene metabolismand other structurallyrelated compounds. Mutation Research, 156, 77–82.
   PubMed Web of Science ®Google Scholar
• GERVASI, P. and LONGO, V., 1990, Metabolism and mutagenicity of isoprene. Environmental Health Perspectives, 86, 85–87.
   PubMed Web of Science ®Google Scholar
• LONGO, V., CITTI, L. and GERVASI, P. G., 1985, Hepatic microsomalmetabolism of isoprene in various rodents. Toxicology Letters, 29, 33–37.
   PubMedGoogle Scholar
• DE MEESTER, C., PONCELET, F., ROBERFROID, M. and MER0ER, M., 1980, Mutagenicity of butadiene towards Salmonella typhimurium . Toxicology Letters, 6, 125–130.
   Google Scholar
• MELNICK, R. L., Hun, J., Cuou, B. J. and MILLER R. A., 1990, Carcinogenicity of 1,3-butadiene in C57BL/6 X C3HF1 mice at low exposure concentrations. Cancer Research, 50, 6592–6599.
   Google Scholar
• MELNICK, R. L. and Hu, J. E., 1993, 1,3-Butadiene induces cancer in experimental animals at all concentrationsfrom 6.25 to 8000 parts per million. In Butadiene and Styrene : Assessment of Health Hazards. IARC Scientific Publications 127, edited by M. Sorsa, K. Peltonen, H. Vainio and K. Hemminki(IARC: Lyon), pp. 309–332.
   Google Scholar
• MELNICK, R. L. and KoHN, M. C., 1995, Mechanistic data indicate that 1,3-butadiene is a human carcinogen. Carcinogerzesis, 16, 157–163.
   PubMed Web of Science ®Google Scholar
• MELNICK, R. L., SILLS, R. C., ROYCROFT, J. H., CHOU, B. J., RAGAN, H. A. and MILLER, R. A., 1994, Isoprene, an endogenous hydrocarbon and industrial chemical, induces multiple organ neoplasia in rodents after 26 weeks of inhalation exposure. Cancer Research, 54, 5333–5339.
   PubMed Web of Science ®Google Scholar
• OWEN, P. E. and GLAISTER, J. R., 1990, Inhalation toxicity and carcinogenicity of 1,3-butadiene in Sprague-Dawley rats. Environmental Health Perspectives, 86, 19–25.
   PubMed Web of Science ®Google Scholar
• PETER, H., W1EGAND, H. J., BOLT, H. M., GREIM, H., WALTER, G., BERG, M. and FILSER, J. G., 1987, Pharmacokinetics of isoprene in rats and mice. Toxicology Letters, 36, 9–14.
   Google Scholar
• PETER, H., WIEGAND, H.-J., FILSER, J. G., BOLT, H. M. and LAIB, R. J., 1990, Inhalation pharmaco-kinetics of isoprene in rats and mice. Environmental Health Perspectives, 86, 89–92.
   Google Scholar
• PLACKE, M. E., LYNCH, M. E., RYAN, M. J., PERSING, R. L., BROOKER, M. J., HOLDREN, M. and Cox, L. A., 1995, The Chronic Inhalation Oncogenicity Study of Isoprene in B6C3F1 Mice. Report to International Institute of Synthetic Rubber Producers, Battelle (Columbus).
   Google Scholar
• SCHURIG, V. and WISTUBA D., 1984, Asymmetric microsomalepoxidation of simple prochiral olefins. Angewandte Chemie International Edition, 23, 796–797.
   Google Scholar
• WISTUBA, D., NOWOTNY, H.-P. TRAGER, O. and SCHURIG, V., 1989, Cytochrome P450-Catalysed asymmetric epoxidation of simple prochiral and chiral aliphatic alkenes: Species dependence and effect of enzyme induction on enantioselective oxirane formation. Chirality, 1, 127–136.
   Google Scholar
• WISTUBA, D. and SCHURIG, V., 1986, Complementaryepoxide hydrolase- vs glutathione S-transferase - catalyzed kinetic resolution of simple aliphatic oxiranes-complete regio- and enantioselective hydrolysis of cis-2-ethyl-3-methyloxirane. Angewandte Chemie International Edition, 25, 1032–1034.
   Google Scholar
• WISTUBA, D., WEIGAND, K. and PETER, H., 1994, Stereoselectivity of in vitro isoprene metabolism. Chemical Research in Toxkology, 7, 336–343.
   PubMedGoogle Scholar